CIK 0001111485 · Accelerated filer
RxSight, Inc.
Sign in to watch- Ticker
- RXST
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943268801
- Phone
- 949-521-7822
- Business address
- 100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
- Former names
- CALHOUN VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,951
- in 4 filings
Net −$117,951. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-03 | Maniar Shweta Director | Grant or award | +19,196 | 19,196 | ||
| 2021-11-17 | Corley Jesse Anderson Director | Purchase | +8,150 | $12.49 | $102K | 14,009 |
| 2021-08-05 | Goldshleger Ilya Chief Operating Officer | Purchase | +1,000 | $14.49 | $14K | 1,000 |
| 2021-08-05 | Goldshleger Ilya Chief Operating Officer | Purchase | +1,372 | $13.69 | $19K | 1,372 |
| 2021-08-05 | Weinberg Eric Chief Commercial Officer | Purchase | +9 | $14.90 | $134 | 925 |
| 2021-08-05 | Kurtz Ronald M MD See Remarks | Purchase | +3,638 | $13.85 | $50K | 804,610 |
| 2021-08-04 | Weinberg Eric Chief Commercial Officer | Purchase | +615 | $16.25 | $10K | 916 |
| 2021-08-03 | Weinberg Eric Chief Commercial Officer | Purchase | +1 | $17.03 | $17 | 301 |
| 2021-08-03 | RxSight I, LLC 10% owner | Conversion | +2,016,778 | 2,016,778 | ||
| 2021-08-03 | RxSight I, LLC 10% owner | Conversion · Series H Preferred Stock | −2,016,778 | 0 | ||
| 2021-08-03 | Wolfen Richard M. Director | Conversion | +76,974 | 78,170 | ||
| 2021-08-03 | Wolfen Richard M. Director | Conversion | +1,489,805 | 1,762,074 | ||
| 2021-08-03 | Wolfen Richard M. Director | Conversion · Series A Preferred Stock | −2,800 | 0 | ||
| 2021-08-03 | Wolfen Richard M. Director | Conversion · Series A Preferred Stock | −11,714 | 0 | ||
| 2021-08-03 | Wolfen Richard M. Director | Conversion · Series B Preferred Stock | −2,017 | 0 | ||
| 2021-08-03 | Wolfen Richard M. Director | Conversion · Series B Preferred Stock | −246,054 | 0 | ||
| 2021-08-03 | Wolfen Richard M. Director | Conversion · Series C Preferred Stock | −398,810 | 0 | ||
| 2021-08-03 | Wolfen Richard M. Director | Conversion · Series D Preferred Stock | −10,807 | 0 | ||
| 2021-08-03 | Wolfen Richard M. Director | Conversion · Series D Preferred Stock | −43,547 | 0 | ||
| 2021-08-03 | Wolfen Richard M. Director | Conversion · Series E Preferred Stock | −4,840 | 0 |
Page 22 of 25 · 491 trades